Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$4.59
NASDAQLPCN
Open
$4.64
Change
$0.13 (2.91%)
Day's Range
$4.51 - $4.65
52-Week Range
$3.30 - $16.15
Volume
7.3K
Market Cap
$406.3M
Currency in USD.
Quote data delayed by at least 15 minutes.